Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Journal of Psychiatry

• Publication date

  2010-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1192/bjp.bp.110.077503PMID 20884951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

  2010cited by this paper
• High-potency cannabis and the risk of psychosis

  2009cited by this paper
• Hippocampal CB1 receptors mediate the memory impairing effects of Δ9-tetrahydrocannabinol

  2009cited by this paper
• The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis.

  2008cited by this paper
• Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  2008cited by this paper
• Effects of a third party observer and anxiety on tests of executive function.

  2008cited by this paper
• Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

  2008cited by this paper
• Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

  2008cited by this paper
• Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance

  2007cited by this paper
• Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

  2007cited by this paper
• Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.

  2007cited by this paper
• The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids : D 9-tetrahydrocannabinol , cannabidiol and D 9-tetrahydrocannabivarin

  2007cited by this paper
• Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

  2006cited by this paper
• The acute effects of cannabinoids on memory in humans: a review

  2006cited by this paper
• Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids

  2005cited by this paper
• Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats.

  2005cited by this paper
• Antianxiety effect of cannabidiol in the elevated plus-maze

  2005cited by this paper
• The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

  2004cited by this paper
• Some correlates of marihuana self-administration in man: A study of titration of intake as a function of drug potency

  2004cited by this paper
• Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users

  2002cited by this paper
• The endogenous cannabinoid system controls extinction of aversive memories

  2002cited by this paper
• Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

  1998cited by this paper
• An event-related potential study of recognition memory with and without retrieval of source.

  1996cited by this paper
• The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.

  1995cited by this paper
• Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.

  1992cited by this paper
• The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.

  1991cited by this paper
• Rivermead Behavioural Memory Test

  1990cited by this paper
• The effects of depression on structural aspects of the recall of prose.

  1989cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Mapping the acute effects of cannabis on multiple memory domains: A randomized, double-blind, placebo-controlled study.

  2026cites this paper
• Naturalistic investigation of cannabis strains varying in THC and CBD ratios and verbal recognition memory

  2026cites this paper
• Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis.

  2025cites this paper
• The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review

  2025cites this paper
• Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.

  2025cites this paper
• Oral cannabidiol did not impair learning and memory in healthy adults

  2025cites this paper
• Temporal Association Between Reported Use of Psychoactive Substances and Cognitive Function in People with Multiple Sclerosis.

  2025cites this paper
• Should cannabis be used in the management of endometriosis?

  2025cites this paper
• A Self-Emulsifying Nanococktail of Pomegranate and Cannabidiol Reduces Cognitive Decline in Mice

  2025cites this paper
• The effect of a synthetic cannabinoid agonist (nabilone) on unimodal tactile illusion correlates with a psychometric scores in healthy volunteers

  2025cites this paper
• The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors

  2025cites this paper
• The Prevalence of Cannabis Use Disorder in Individuals with Anxiety or Related Disorders: A Systematic Review

  2025cites this paper
• Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research

  2024cites this paper
• Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis

  2024cites this paper
• Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)

  2024cites this paper
• Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families: A Mixed-Methods Analysis

  2024cites this paper
• Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial

  2024cites this paper
• Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults

  2023cites this paper
• Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence

  2023cites this paper
• Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation

  2023cites this paper
• THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

  2023cites this paper
• Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  2023cites this paper
• Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

  2023cites this paper
• Cognitive test performance in chronic cannabis flower users, concentrate users, and non-users

  2023cites this paper
• An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry

  2023cites this paper
• CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.

  2023cites this paper
• A comprehensive review of natural product-derived compounds acting on P2X7R: The promising therapeutic drugs in disorders.

  2023cites this paper
• Ameliorative Effect of Cannabidiol on Topiramate-Induced Memory Loss: The Role of Hippocampal and Prefrontal Cortical NMDA Receptors and CREB/BDNF Signaling Pathways in Rats

  2023cites this paper
• Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development.

  2023cites this paper
• Cannabis use in relation to Pulse Pressure and Mean Arterial Pressure in US Adults

  2023cites this paper
• Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

  2023cites this paper
• Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms

  2023cites this paper
• Sativex® for the treatment of Agitation & Aggression in Alzheimer’s Dementia in UK nursing homes (STAND): Protocol for a feasibility randomised controlled trial

  2023cites this paper
• The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review

  2023cites this paper
• Should oncologists trust cannabinoids?

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Perspectives toward cannabidiol (CBD) among youth in Early Psychosis Intervention programs: A qualitative study

  2023cites this paper
• Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios

  2022cites this paper
• A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

  2022cites this paper
• Cannabis and Driving: Developing Guidelines for Safety Policies.

  2022cites this paper
• Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations

  2022cites this paper
• Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development.

  2022cites this paper
• Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives

  2022cites this paper
• Evidence from naturalistic studies can be strengthened by triangulation

  2022cites this paper
• Cannabidiol in the context of substance use disorder treatment: A systematic review.

  2022cites this paper
• Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats with Persistent Inflammatory Pain.

  2022cites this paper
• A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use

  2022cites this paper
• Cannabidiol modulation of hippocampal glutamate in early psychosis

  2021cites this paper
• Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  2021cites this paper
• Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs

  2021cites this paper
• The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

  2021cites this paper
• An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results

  2021cites this paper
• Drug Resistance in Diabetes

  2021cites this paper
• Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making

  2021cites this paper
• A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users

  2021cites this paper
• Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review

  2021cites this paper
• Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study

  2021cites this paper
• Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?

  2021cites this paper
• The effect of cannabis toxicity on a model microbiome bacterium epitomized by a panel of bioluminescent E. coli.

  2021cites this paper
• Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial.

  2021cites this paper
• A scoping review of the use of cannabidiol in psychiatric disorders.

  2021cites this paper
• Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates.

  2021cites this paper
• Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray

  2021cites this paper
• Cannabidiol and the central nervous system: translating into clinics

  2021cites this paper
• Cannabis and Autoimmunity: Possible Mechanisms of Action

  2021cites this paper
• Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults

  2021cites this paper
• Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts

  2021cites this paper
• More harm than good? Cannabis, harm and the misuse of drugs act

  2021cites this paper
• Minimally Invasive Surgery for Chronic Pain Management: An Evidence-Based Approach

  2020cites this paper
• Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy

  2020cites this paper
• Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

  2020cites this paper
• Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users

  2020cites this paper
• Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages

  2020cites this paper
• Roles of Cannabidiol in Reversing Proteinopathies

  2020cites this paper
• The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study

  2020cites this paper
• Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.

  2020cites this paper
• Interaction of Cannabis Use and Aging: From Molecule to Mind

  2020cites this paper
• Deconstructing the neurobiology of cannabis use disorder

  2020cites this paper
• Cannabis and Neuropsychiatric Effects

  2020cites this paper
• Online information on medical cannabis may rise unrealistic expectations and downplay potential side effects

  2020cites this paper
• The molecular mechanisms that underpin the biological benefit of full spectrum cannabis extract in the treatment of neuropathic pain and inflammation.

  2020cites this paper
• Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective

  2020cites this paper
• Mapping cannabis potency in medical and recreational programs in the United States

  2020cites this paper
• Medical Cannabis in Children

  2020cites this paper
• Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder

  2020cites this paper
• The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders

  2020cites this paper
• Emerging potential of cannabidiol in reversing proteinopathies.

  2020cites this paper
• Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers

  2020cites this paper
• The Long-Term Effect of CBD Crystals and CBD Oil on Depressive-Associated Rat Behaviors

  2020cites this paper
• Neuroprotection Following Concussion: The Potential Role for Cannabidiol

  2020cites this paper
• Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

  2020cites this paper
• Neuroscience

  2020cites this paper
• Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys

  2020cites this paper
• Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence

  2020cites this paper
• Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process.

  2020cites this paper
• Challenging CBD protective effect against THC-related outcomes: a call for robust clinical trials.

  2020cites this paper
• Cognitive sequelae of cannabis use

  2020cites this paper
• Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?

  2020cites this paper
• Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.

  2020cites this paper
• Use of Medical Cannabis to Treat Traumatic Brain Injury

  2020cites this paper